{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:15:51Z","timestamp":1777284951775,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jad.2022.01.104","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T19:16:49Z","timestamp":1643483809000},"page":"91-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression"],"prefix":"10.1016","volume":"303","author":[{"given":"Lynnette A.","family":"Averill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Averill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralitza","family":"Gueorguieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Heup","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohini","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak Cyril","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Southwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Sanacora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald S.","family":"Duman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadi G.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.01.104_bib0024","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"Aan Het Rot","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.12718","article-title":"Ketamine as a promising prototype for a new generation of rapid-acting antidepressants","author":"Abdallah","year":"2015","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jad.2022.01.104_bib0026","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","article-title":"Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics","volume":"66","author":"Abdallah","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jad.2022.01.104_bib0039","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/nyas.12718","article-title":"Ketamine as a promising prototype for a new generation of rapid-acting antidepressants","volume":"1344","author":"Abdallah","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2022.01.104_bib0041","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2018.05.010","article-title":"The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation?","volume":"190","author":"Abdallah","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2022.01.104_bib0053","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","volume":"45","author":"Abdallah","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2022.01.104_bib0051","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jad.2022.01.104_bib0027","first-page":"99","volume":"7","author":"Averill","year":"2016"},{"issue":"3","key":"10.1016\/j.jad.2022.01.104_bib0028","article-title":"Ketamine for stress-related psychopathology and suicidality: a brief update","volume":"36","author":"Averill","year":"2019","journal-title":"Psychiatr. Times"},{"key":"10.1016\/j.jad.2022.01.104_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.apha.2020.04.003","article-title":"Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence","volume":"89","author":"Averill","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jad.2022.01.104_bib0067","volume":"63","author":"Beck","year":"1991"},{"key":"10.1016\/j.jad.2022.01.104_bib0008","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamapsychiatry.2019.0174","article-title":"Prediction models for suicide attempts and deaths: a systematic review and simulation","volume":"76","author":"Belsher","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0023","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0009","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1017\/S0033291702006943","article-title":"Psychological autopsy studies of suicide: a systematic review","volume":"33","author":"Cavanagh","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2022.01.104_bib0004","series-title":"Increase in Suicide in the United States, 1999\u20132014","first-page":"1","author":"Curtin","year":"2016"},{"key":"10.1016\/j.jad.2022.01.104_bib0030","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0062","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbr.2013.08.047","article-title":"Inhibition of mTOR kinase via rapamycin blocks persistent predator stress-induced hyperarousal","volume":"256","author":"Fifield","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jad.2022.01.104_bib0054","doi-asserted-by":"crossref","first-page":"e1226","DOI":"10.1038\/tp.2017.179","article-title":"Gene expression associated with suicide attempts in US veterans","volume":"7","author":"Flory","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0042","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-pharmtox-010617-052811","article-title":"Molecular pharmacology and neurobiology of rapid-acting antidepressants","volume":"59","author":"Gould","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2022.01.104_bib0056","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1101\/lm.027664.112","article-title":"A recollection of mTOR signaling in learning and memory","volume":"20","author":"Graber","year":"2013","journal-title":"Learn. Mem."},{"key":"10.1016\/j.jad.2022.01.104_bib0012","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.amepre.2014.06.012","article-title":"Existing and novel biological therapeutics in suicide prevention","volume":"47","author":"Griffiths","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.jad.2022.01.104_bib0033","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2022.01.104_bib0034","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0049","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/mp.2015.211","article-title":"Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation","volume":"21","author":"Harraz","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0002","series-title":"Suicide mortality in the United States, 1999\u20132017","author":"Hedegaard","year":"2018"},{"key":"10.1016\/j.jad.2022.01.104_bib0003","volume":"309","author":"Hedegaard","year":"2018"},{"key":"10.1016\/j.jad.2022.01.104_bib0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.schres.2004.05.015","article-title":"Suicidal risk during treatment with clozapine: a meta-analysis","volume":"73","author":"Hennen","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2022.01.104_bib0057","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","article-title":"mTOR signaling: at the crossroads of plasticity, memory and disease","volume":"33","author":"Hoeffer","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jad.2022.01.104_bib0070","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mp.2015.19","article-title":"Mental disorders and risk of suicide attempt: a national prospective study","volume":"20","author":"Hoertel","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0007","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamapsychiatry.2018.4564","article-title":"Suicide reduction and research efforts in service members and veterans\u2014sobering realities","volume":"76","author":"Hoge","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0044","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/bcp.12845","article-title":"New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs","volume":"82","author":"Ignacio","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2022.01.104_bib0059","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","article-title":"The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder","volume":"35","author":"Jernigan","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2017.03.013","article-title":"Clozapine and incidence of myocarditis and sudden death \u2013 long term Australian experience","volume":"238","author":"Khan","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jad.2022.01.104_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.011008.145557","article-title":"Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies","volume":"49","author":"Kovacsics","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2022.01.104_bib0058","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5607\/en.2015.24.3.177","article-title":"Roles of mTOR signaling in brain development","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.jad.2022.01.104_bib0046","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jad.2022.01.104_bib0052","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0018","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jad.2018.08.036","article-title":"Understanding suicide: focusing on its mechanisms through a lithium lens","volume":"241","author":"Malhi","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.01.104_bib0063","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2020.107328","article-title":"Acute exercise enhances fear extinction through a mechanism involving central mTOR signaling","volume":"176","author":"Moya","year":"2020","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.jad.2022.01.104_bib0038","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0064","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0035","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2022.01.104_bib0043","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jad.2022.01.104_bib0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41398-020-0782-1","article-title":"The potential role of the HCN1 ion channel and BDNF-mTOR signaling pathways and synaptic transmission in the alleviation of PTSD","volume":"10","author":"Ni","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0055","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/mp.2015.112","article-title":"Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach","volume":"20","author":"Niculescu","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.9740\/mhc.n166825","article-title":"Management and prevention of agranulocytosis in patients receiving clozapine","volume":"3","author":"Ojong","year":"2013","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.jad.2022.01.104_bib0017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/104012371502700404","article-title":"The risk of suicide after clozapine discontinuation: cause for concern","volume":"27","author":"Patchan","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2022.01.104_bib0022","article-title":"Psychopharmacological treatment to reduce suicide risk","volume":"18","author":"Pompili","year":"2019","journal-title":"Ann Gen Psychiatry."},{"key":"10.1016\/j.jad.2022.01.104_bib0068","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12991-019-0232-8","article-title":"Critical appraisal of major depression with suicidal ideation","volume":"18","author":"Pompili","year":"2019","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0050","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8236.1","article-title":"In search of the mechanisms of ketamine's antidepressant effects: how robust is the evidence behind the mTor activation hypothesis","volume":"5","author":"Popp","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.jad.2022.01.104_bib0029","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0036","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/da.22253","article-title":"Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression","volume":"31","author":"Price","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2022.01.104_bib0032","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s40473-019-00184-3","article-title":"Infusing hope into the treatment of suicidality: a review of ketamine's effects on suicidality","volume":"6","author":"Rengasamy","year":"2019","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"10.1016\/j.jad.2022.01.104_bib0069","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1192\/bjp.2018.27","article-title":"Depression and hopelessness as risk factors for suicide ideation, attempts and death: meta-analysis of longitudinal studies","volume":"212","author":"Ribeiro","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.9740\/mhc.2015.09.237","article-title":"Lithium and clozapine in suicidality: shedding some light to get out of the dark","volume":"5","author":"Riesselman","year":"2015","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.jad.2022.01.104_bib0066","doi-asserted-by":"crossref","unstructured":"Rush, A.J., Trivedi, M.H., Ibrahim, H.M., Carmody, T.J., Arnow, B., Klein, D.N., Markowitz, J.C., Ninan, P.T., Kornstein, S., Manber, R., Thase, M.E., Kocsis, J.H., Keller, M.B., 2003. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry 54, 573\u2013583. https:\/\/doi.org\/10.1016\/S0006-3223(02)01866-8.","DOI":"10.1016\/S0006-3223(02)01866-8"},{"key":"10.1016\/j.jad.2022.01.104_bib0021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/bdi.12543","article-title":"Lithium and suicide in mood disorders: updated meta-review of the scientific literature","volume":"19","author":"Smith","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2022.01.104_bib0019","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/a-0596-7853","article-title":"Antisuicidal effects in mood disorders: are they unique to lithium?","volume":"51","author":"Tondo","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0040","unstructured":"US Food and Drug Administration, 2020 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211243lbl.pdf."},{"key":"10.1016\/j.jad.2022.01.104_bib0014","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.genhosppsych.2017.02.004","article-title":"Clozapine induced gastrointestinal hypomotility: a potentially life threatening adverse event. A review of the literature","volume":"46","author":"West","year":"2017","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0004867419883341","article-title":"Ketamine for suicidal ideation in adults with psychiatric disorders: a systematic review and meta-analysis of treatment trials","volume":"54","author":"Witt","year":"2020","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0001","unstructured":"Substance Abuse and Mental Health Services Administration. (2020) Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality. Retrieved from: https:\/\/www.samhsa.gov\/data\/externalicon."},{"key":"10.1016\/j.jad.2022.01.104_bib0005","volume":"355","author":"Xu","year":"2020"},{"key":"10.1016\/j.jad.2022.01.104_bib0048","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03009734.2012.724118","article-title":"Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test","volume":"118","author":"Yang","year":"2013","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.jad.2022.01.104_bib0065","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0037","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.01.104_bib0047","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"Eur. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272200115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272200115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T02:43:50Z","timestamp":1759027430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503272200115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":69,"alternative-id":["S016503272200115X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.01.104","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.01.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}